Faced with a very limited staff, the National Pharmaceutical Pricing Authority (NPPA) is finding itself unable to calculate the companies’ penalty and has instead left that up to the individual companies. So… how do you think this will turn out? Read more here. (Source: Business Standard, 1/20/14).
